{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:09:30Z","timestamp":1790885370073,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bmc.2022.117012","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T12:36:36Z","timestamp":1663158996000},"page":"117012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Synthesis and preclinical evaluation of rhenium and technetium-99m \u201c4\u00a0+\u00a01\u201d mixed-ligand complexes bearing quinazoline derivatives as potential EGFR imaging agents"],"prefix":"10.1016","volume":"73","author":[{"given":"Christos","family":"Kiritsis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Shegani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Makrypidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Roupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristotelis","family":"Lazopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Panagiotopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiria","family":"Triantopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Paravatou-Petsotas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00fcrgen","family":"Pietzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pelecanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minas","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Pirmettis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2022.117012_b0005","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/1568026620666200303123102","article-title":"Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors","volume":"20","author":"Sabbah","year":"2020","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2022.117012_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2004-829641","article-title":"Epidermal growth factor receptor inhibitors in lung cancer therapy","volume":"25","author":"Laskin","year":"2004","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.bmc.2022.117012_b0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJMra044389","article-title":"Tyrosine kinases as targets for cancer therapy","volume":"353","author":"Krause","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bmc.2022.117012_b0020","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.bmc.2022.117012_b0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrc2088","article-title":"Epidermal growth factor receptor mutations in lung cancer","volume":"7","author":"Sharma","year":"2007","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.bmc.2022.117012_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133164","article-title":"Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies","volume":"13","author":"Khaddour","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bmc.2022.117012_b0035","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1152\/physrev.00030.2015","article-title":"Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease","volume":"96","author":"Chen","year":"2016","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.bmc.2022.117012_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105164","article-title":"Natural tyrosine kinase inhibitors acting on the epidermal growth factor receptor: Their relevance for cancer therapy","volume":"161","author":"Liang","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.bmc.2022.117012_b0045","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1517\/13543784.2014.928283","article-title":"Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer","volume":"23","author":"Lee","year":"2014","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.bmc.2022.117012_b0050","first-page":"67","article-title":"Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review, Transl. Lung","volume":"4","author":"Stewart","year":"2015","journal-title":"Cancer Research"},{"key":"10.1016\/j.bmc.2022.117012_b0055","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/med.21299","article-title":"Imaging EGFR and HER2 by PET and SPECT: A Review","volume":"34","author":"Corcoran","year":"2014","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/j.bmc.2022.117012_b0060","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/ph7030311","article-title":"Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy","volume":"7","author":"Sihver","year":"2014","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmc.2022.117012_b0065","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.3390\/ijms22073663","article-title":"PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology","volume":"22","author":"Rinne","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.bmc.2022.117012_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103855","article-title":"Synthesis, characterization and evaluation of 68Ga labelled monomeric and dimeric quinazoline derivatives of the HBED-CC chelator targeting the epidermal growth factor receptor","volume":"100","author":"Liolios","year":"2020","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/j.bmc.2022.117012_b0075","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jlcr.998","article-title":"Fluorine-18 labeling of 6,7-disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: synthesis of 18F-Iressa and related molecular probes","volume":"48","author":"Seimbille","year":"2005","journal-title":"J. Labelled Comp. Radiopharm."},{"key":"10.1016\/j.bmc.2022.117012_b0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.apradiso.2011.09.005","article-title":"Automated synthesis of [18F]gefitinib on a modular system","volume":"70","author":"L\u00e4ppchen","year":"2012","journal-title":"Applied Radiation and Isotopes"},{"key":"10.1016\/j.bmc.2022.117012_b0085","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.apradiso.2009.07.018","article-title":"A fully automated two-step synthesis of an 18F-labelled tyrosine kinase inhibitor for EGFR kinase activity imaging in tumors","volume":"67","author":"Kobus","year":"2009","journal-title":"Applied Radiation and Isotopes"},{"key":"10.1016\/j.bmc.2022.117012_b0090","doi-asserted-by":"crossref","unstructured":"N.E.M. Kaufman, S. Dhingra, S.D. Jois, M.d.G.H. Vicente, Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR), Molecules, 26 (2021).","DOI":"10.3390\/molecules26041076"},{"key":"10.1016\/j.bmc.2022.117012_b0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11307-009-0265-5","article-title":"[11C]Gefitinib ([11C]Iressa): Radiosynthesis, In Vitro Uptake, and In Vivo Imaging of Intact Murine Fibrosarcoma","volume":"12","author":"Zhang","year":"2010","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.bmc.2022.117012_b0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.nucmedbio.2003.12.005","article-title":"Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors","volume":"31","author":"Mishani","year":"2004","journal-title":"Nuclear Medicine and Biology"},{"key":"10.1016\/j.bmc.2022.117012_b0105","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11307-006-0049-0","article-title":"Molecular Imaging of EGFR Kinase Activity in Tumors with 124I-Labeled Small Molecular Tracer and Positron Emission Tomography","volume":"8","author":"Pal","year":"2006","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.bmc.2022.117012_b0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.nucmedbio.2011.09.001","article-title":"Radiohalogenated 4-anilinoquinazoline-based EGFR-TK inhibitors as potential cancer imaging agents","volume":"39","author":"Neto","year":"2012","journal-title":"Nuclear Medicine and Biology"},{"key":"10.1016\/j.bmc.2022.117012_b0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12149-010-0432-4","article-title":"Evaluation of radioiodinated quinazoline derivative as a new ligand for EGF receptor tyrosine kinase activity using SPECT","volume":"25","author":"Hirata","year":"2011","journal-title":"Annals of Nuclear Medicine"},{"key":"10.1016\/j.bmc.2022.117012_b0120","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1016\/j.bmc.2007.04.008","article-title":"Radioiodination of new EGFR inhibitors as potential SPECT agents for molecular imaging of breast cancer","volume":"15","author":"Fernandes","year":"2007","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2022.117012_b0125","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1039\/c004797j","article-title":"Synthesis, characterization and biological evaluation of In(iii) complexes anchored by DOTA-like chelators bearing a quinazoline moiety\u2020","volume":"2","author":"Garcia","year":"2010","journal-title":"Metallomics"},{"key":"10.1016\/j.bmc.2022.117012_b0130","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10967-016-5019-7","article-title":"A review on evaluation of technetium-99m labeled radiopharmaceuticals","volume":"310","author":"Akbar","year":"2016","journal-title":"Journal of Radioanalytical and Nuclear Chemistry"},{"key":"10.1016\/j.bmc.2022.117012_b0135","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/jlcr.3531","article-title":"Technetium-99m radiochemistry for pharmaceutical applications","volume":"60","author":"Papagiannopoulou","year":"2017","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.bmc.2022.117012_b0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00259-013-2542-4","article-title":"Quantitative SPECT\/CT: SPECT joins PET as a quantitative imaging modality","volume":"41","author":"Bailey","year":"2014","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.bmc.2022.117012_b0145","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nucmedbio.2020.05.005","article-title":"Review on 99mTc radiopharmaceuticals with emphasis on new advancements","volume":"92","author":"Duatti","year":"2021","journal-title":"Nuclear Medicine and Biology"},{"key":"10.1016\/j.bmc.2022.117012_b0150","article-title":"Rhenium and technetium complexes bearing quinazoline derivatives: progress towards a 99mTc biomarker for EGFR-TK imaging","volume":"3215\u20133225","author":"Fernandes","year":"2008","journal-title":"Dalton Transactions"},{"key":"10.1016\/j.bmc.2022.117012_b0155","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1016\/j.ejmech.2009.04.033","article-title":"Synthesis and characterization of rhenium and technetium-99m tricarbonyl complexes bearing the 4-[3-bromophenyl]quinazoline moiety as a biomarker for EGFR-TK imaging","volume":"44","author":"Bourkoula","year":"2009","journal-title":"European Journal of Medical Chemistry"},{"key":"10.1016\/j.bmc.2022.117012_b0160","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1021\/acs.molpharmaceut.9b00540","article-title":"Synthesis and Biological Evaluation of Novel 99mTc-Labeled Palbociclib Derivatives Targeting Cyclin-Dependent Kinase 4\/6 (CDK4\/6) as Potential Cancer Imaging Agents","volume":"16","author":"Song","year":"2019","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.bmc.2022.117012_b0165","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1021\/jm00018a008","volume":"38","author":"Rewcastle","year":"1995","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2022.117012_b0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0020-1693(95)04571-6","article-title":"Synthesis and reactions of trigonal-bipyramidal rhenium and technetium complexes with a tripodal, tetradentate NS3 ligand","volume":"240","author":"Spies","year":"1995","journal-title":"Inorganica Chim. Acta"},{"key":"10.1016\/j.bmc.2022.117012_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116373","article-title":"Synthesis and evaluation of new mixed \u201c2 + 1\u201d Re, 99mTc and 186Re tricarbonyl dithiocarbamate complexes with different monodentate ligands","volume":"47","author":"Shegani","year":"2021","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2022.117012_b0180","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1021\/jm960273y","article-title":"Novel 99mTc aminobisthiolato\/monothiolato '3 + 1' mixed ligand complexes: Structure-activity relationships and preliminary in vivo validation as brain blood flow imaging agents","volume":"40","author":"Pirmettis","year":"1997","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2022.117012_b0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/jlcr.3372","article-title":"Synthesis, characterization, and biological evaluation of new biotinylated 99mTc\/Re-tricarbonyl complexes","volume":"59","author":"Makris","year":"2016","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.bmc.2022.117012_b0190","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1021\/bc0001591","article-title":"Mixed-Ligand Technetium(III) Complexes with Tetradendate\/Monodendate NS3\/Isocyanide Coordination: A New Nonpolar Technetium Chelate System for the Design of Neutral and Lipophilic Complexes Stable in Vivo","volume":"12","author":"Pietzsch","year":"2001","journal-title":"Bioconjugate Chemistry"},{"key":"10.1016\/j.bmc.2022.117012_b0195","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0969-8051(01)00313-4","article-title":"Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT1A receptor and the alpha1-adrenergic receptor","volume":"29","author":"Heimbold","year":"2002","journal-title":"Nuclear Medicine and Biology"},{"key":"10.1016\/j.bmc.2022.117012_b0200","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/MNM.0b013e32822a0d9f","article-title":"Myocardial uptake and biodistribution of newly designed technetium-labelled fatty acid analogues","volume":"28","author":"Heintz","year":"2007","journal-title":"Nuclear Medicine Communications"},{"key":"10.1016\/j.bmc.2022.117012_b0205","first-page":"33","article-title":"Comparison of in vitro and in vivo properties of [99mTc]cRGD peptides labeled using different novel Tc-cores","volume":"51","author":"Decristoforo","year":"2007","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.bmc.2022.117012_b0210","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.nucmedbio.2011.12.012","article-title":"Synthesis, in vitro and in vivo characterization of novel 99mTc-\u20184+1\u2019-labeled 5-nitroimidazole derivatives as potential agents for imaging hypoxia","volume":"39","author":"Giglio","year":"2012","journal-title":"Nuclear Medicine and Biology"},{"key":"10.1016\/j.bmc.2022.117012_b0215","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1021\/bc049745a","article-title":"Mixed-Ligand Rhenium-188 Complexes with Tetradentate\/Monodentate NS3\/P (\u20184 + 1') Coordination: Relation of Structure with Antioxidation Stability","volume":"16","author":"Schiller","year":"2005","journal-title":"Bioconjugate Chemistry"},{"key":"10.1016\/j.bmc.2022.117012_b0220","series-title":"Drug-Like Properties (Second Edition)","first-page":"39","article-title":"Chapter 5 - Lipophilicity","author":"Di","year":"2016"},{"key":"10.1016\/j.bmc.2022.117012_b0225","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00259-007-0636-6","article-title":"Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors","volume":"35","author":"Su","year":"2008","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.bmc.2022.117012_b0230","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0969-8051(01)00200-1","article-title":"Potential 18F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase","volume":"28","author":"Bonasera","year":"2001","journal-title":"Nuclear Medicine and Biology"},{"key":"10.1016\/j.bmc.2022.117012_b0235","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/ijc.10619","article-title":"Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug","volume":"101","author":"Ortu","year":"2002","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.bmc.2022.117012_b0240","first-page":"21","article-title":"Minimizing liver uptake of cationic Tc radiotracers with ether and crown ether functional groups, World","volume":"2","author":"Kim","year":"2010","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.bmc.2022.117012_b0245","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.2174\/138161208786404326","article-title":"Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities","volume":"14","author":"Mishani","year":"2008","journal-title":"Current Pharmaceutical Design"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622004059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622004059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:20:25Z","timestamp":1760836825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622004059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":49,"alternative-id":["S0968089622004059"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.117012","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and preclinical evaluation of rhenium and technetium-99m \u201c4\u00a0+\u00a01\u201d mixed-ligand complexes bearing quinazoline derivatives as potential EGFR imaging agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.117012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117012"}}